Senesco Technologies Inc Sample Contracts

AutoNDA by SimpleDocs
AGREEMENT ---------
Registration Rights Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. • November 13th, 2023 • Biological products, (no disgnostic substances)

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 19, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to 380,590 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 6th, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December ____, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 29th, 2010 • Senesco Technologies Inc • Services-commercial physical & biological research

This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 26, 2010, between Senesco Technologies Inc., a Delaware corporation (the “Company”), and each of the purchasers who are signatories hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

WARRANT -------
Senesco Technologies Inc • January 2nd, 2002 • Services-commercial physical & biological research • Delaware
AGREEMENT ---------
Registration Rights Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
AGREEMENT ---------
Registration Rights Agreement • January 2nd, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
Warrant No. [ ] Number of Shares: [ ] (subject to adjustment)
Senesco Technologies Inc • May 9th, 2002 • Services-commercial physical & biological research • New Jersey
SECTION I
Common Stock Purchase Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
PRE-FUNDED COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. • January 25th, 2024 • Biological products, (no disgnostic substances)

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, SD MF 4 LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to 471,508 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SECTION I
Securities Purchase Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECTION I
Securities Purchase Agreement • February 14th, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • November 13th, 2023 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of September 18, 2023, between Eloxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

AutoNDA by SimpleDocs
ELOXX PHARMACEUTICALS, INC. AND [•], AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF COMMON STOCK WARRANT AGREEMENT
Warrant Agreement • November 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York

THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 1st, 2013 • Senesco Technologies Inc • Services-commercial physical & biological research • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of September 30, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

AGREEMENT ---------
Registration Rights Agreement • September 28th, 2000 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
ELOXX PHARMACEUTICALS, INC. Shares of Common Stock ($0.01 par value per share) SALES AGREEMENT
Sales Agreement • May 24th, 2023 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York

Eloxx Pharmaceuticals, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. (the “Agent”), as follows:

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 29th, 2010 • Senesco Technologies Inc • Services-commercial physical & biological research • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 26, 2010, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

COMMON STOCK PURCHASE WARRANT Senesco Technologies, Inc.
Senesco Technologies Inc • December 12th, 2013 • Services-commercial physical & biological research

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after December ___, 2013 (the “Initial Exercise Date”) and on or prior to the close of business on the sixth month anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Senesco Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SECTION I
Securities Purchase Agreement • January 2nd, 2002 • Senesco Technologies Inc • Services-commercial physical & biological research • Delaware
ELOXX PHARMACEUTICALS, INC. and [•], AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENT
Warrant Agreement • November 16th, 2018 • Eloxx Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York

This DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

WARRANT -------
Senesco Technologies Inc • January 2nd, 2002 • Services-commercial physical & biological research • Delaware
RECITALS
Development and License Agreement • May 17th, 2004 • Senesco Technologies Inc • Services-commercial physical & biological research • New York
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!